Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

Singular Health Group signs MOU and completes equity placement

  • In News
  • November 20, 2024
  • Gracen Moore
Singular Health Group signs MOU and completes equity placement

Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an AUD0.5M cornerstone investment by PNS.

  • Singular Health and Miami-based Managed Service Organisation PNS have signed a MOU for Singular Health’s 3Dicom software.
  • The MOU provides a definitive pathway towards an initial commercial pilot, a subsequent full-scale rollout throughout the PNS network, and a planned National rollout to PNS’ wider network.
  • Singular Health’s Medical File Transfer Protocol (MFTP) enables access to imaging data across disparate PACS networks, regardless of location, resulting in a potential reduction of duplicate imaging costs to payors, risk providers and Managed Service Organisations.
  • Singular Health completes a successful equity placement of AUD3.7M at $0.09 per share, including an AUD0.5M cornerstone investment by PNS.
  • These new funds will be directed towards further development of the 3Dicom software, the MOU implementation and advancement towards a commercial pilot program along with working capital.

PNS is a Miami-based Managed Service Organisation (MSO) with operations in Florida, Texas, and Puerto Rico, managing the provision of healthcare for more than 3.7M Member Plans.

Throughout 2024, Singular Health has, in collaboration with PNS, co-designed a forward workplan and bespoke solution to demonstrate the feasibility of Singular Health’s 3Dicom solution in solving multiple, highly valuable workflows, within PNS’s network to target the reduction in duplicate imaging and improving access to imaging across disparate PACs  systems along with applying analysis to historical and recent images.

Commenting on the PNS MOU, Singular Health’s Managing Director and CEO, Denning Chong said: “We look ahead to the technical proof-of-concept, which is expected to commence in the coming days and to solidify our relationship with PNS in the coming weeks and months. Our focus on providing solutions to MSOs is part of Singular’s scalable business model that would ultimately lead to significant contracts. Our collaboration with PNS during 2024 has given us confidence in our 3Dicom software and its application to other MSOs in the substantial US market.”

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025
  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI - July 17, 2025
  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform - July 11, 2025
  •  
  •  
  •  
  •  
  • ASX:SHG
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025
  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI - July 17, 2025
  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform - July 11, 2025

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S. - July 18, 2025
  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI - July 17, 2025
  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform - July 11, 2025
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.